STL Volume 9 Number 1

Over the past decade, refinements in laser technology as well as advances in laser techniques have enabled dermatologic surgeons to define the most appropriate lasers to use for different scar types without the adverse sequelae and recurrence rates noted with older surgical revision techniques and continuous wave laser systems.

Many of the treatment options available can cause discomfort, pain or skin irritation. Topical 3% diclofenac in 2.5% hyaluronan gel (Solaraze™, Bioglan Pharma) is a relatively new treatment that has been shown to be effective and well tolerated for the treatment of AKs.